Theragen ETEX Bio Institute said Tuesday that it has agreed to expand HelloGene, a personal genome analysis service with three partners -- Kwak Sang Ro Obstetrician-Gynecologist Clinic, Samkwang Medical Laboratories and Genome Care.
|Theragen ETEX Bio Institute CEO and President Hwang Tae-soon (second from right) and Noh Sung-hoon, director of Kwak Sang Ro Obstetrician-Gynecologist Clinic, shake hands after signing the memorandum of understanding at the clinic in Seongnam, just south of Seoul, Tuesday.|
Under the accord, the four companies and hospitals will cooperate to expand HelloGene and Genomom, a non-invasive antenatal diagnosis service. They also plan to jointly research genome data and establish a business partnership through genome analysis.
“We will provide our non-invasive antenatal diagnosis test Genomom and personal genome analysis service HelloGene to Kwak Sang Ro Obstetrician-Gynecologist Clinic, one of the best gynecologic clinics in Korea,” said Theragen ETEX Bio Institute CEO and President Hwang Tae-soon. “Hospital, company and laboratory will work together to promote the best health care services for their customers.”
Kwak Sang Ro Obstetrician-Gynecologist Clinic also showed enthusiasm about the MOU.
“Through genetic analysis, we hope that the optimal health care for the individual will be popularized,” Kwak Sang Ro Obstetrician-Gynecologist Clinic Director Noh Sung-hoon said. “We expect synergy between genetic analysis technology, distribution and management, and business cooperation between leading companies regarding services.”
Theragen ETEX Bio Institute is one of the leading domestic companies. Some of Theragen’s most significant feats include becoming the first Korean company to succeed in analyzing individual genomes and identifying Korean gastric cancer gene.
<© Korea Biomedical Review, All rights reserved.>